MDGL:NASDAQ
Madrigal Pharmaceuticals Inc
$487.72
arrow_downward
-1.76%(-8.73) 1D
$487.72
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MDGL...
Open
$492.69
High
$502.34
Low
$486.77
Mkt. cap
11.27B
Avg. vol.
232.12K
Volume
256.25K
52-wk high
$614.36
52-wk low
$393.60
EPS
-$12.87
Beta
-1.04
Shares outstanding
23.10M
No. of employees
915
Open
$492.69
High
$502.34
Low
$486.77
Mkt. cap
11.27B
Avg. vol.
232.12K
Volume
256.25K
52-wk high
$614.36
52-wk low
$393.60
EPS
-$12.87
Beta
-1.04
Shares outstanding
23.10M
No. of employees
915
News stories
From web sources and news partners
Simply Wall Street
·
6 hours ago
Is Madrigal Pharmaceuticals (MDGL) Undervalued As New Rezdiffra Genetic Data Broadens Its MASH Case?
Yahoo Finance
·
6 hours ago
Is Rezdiffra’s Genetic-Risk Agnostic Data Reframing The Investment Case For Madrigal Pharmaceuticals (MDGL)?
Zacks
·
13 hours ago
Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?
AD HOC NEWS
·
22 hours ago
Madrigal Pharmaceuticals stock gets fresh Rezdiffra data
About Madrigal Pharmaceuticals Inc
CEOPaul A. Friedman
Employees915
Founded2011
HeadquartersWest Conshohocken, Pennsylvania, United States
SectorBiotechnology
Websitemadrigalpharma.com